Moderna Sinks 4% After 18% Plunge as Melanoma Vaccine Selloff Extends; Merck and Pfizer Slip24/7 Wall Street • 10/23/26
Moderna, Meta, SpaceX, AT&T, CoreWeave, Sandisk, and More Stocks That Explain Today's MarketBarrons • 10/23/26
Stock Market Today, Oct. 22: Moderna Stock Plummets 18% on Melanoma Vaccine Data Leak ReportsThe Motley Fool • 10/22/26
Moderna sheds about $24 billion as cancer vaccine data triggers 'sell-the-news' retreatReuters • 10/22/26
Merck and Moderna Will Present Results From Landmark Phase 3 INTerpath-001 Trial for Intismeran Autogene Plus KEYTRUDA® (pembrolizumab) at ESMO 2026 Presidential SymposiumBusiness Wire • 10/22/26
Moderna shares plunged after details from a closely guarded mRNA-based cancer vaccine study were shared on social mediaWSJ • 10/22/26
Moderna Tumbles 25% After Apparent Early Leak of Melanoma Vaccine Data; BioNTech Dips, Pfizer Edges Higher24/7 Wall Street • 10/22/26
Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.Market Watch • 10/21/26
Moderna's Respiratory Portfolio Expands: Can It Reduce COVID Reliance?Zacks Investment Research • 10/21/26